交易 Celon Pharma SA - CLNP 差價合約

交易條件

• 類型: 差價合約
• 點差: 0.200
• 長倉隔夜倉息調整: -0.02148%
• 短倉隔夜倉息調整: -0.00044%
• 隔夜倉息調整時間: 21:00 (UTC)
• 貨幣: PLN
• 最低成交量: 0.1
• 保證金: 20.00%
• 證券交易所: Poland
• 交易佣金: 0%
• 保證止損溢價: 1%

主要統計數據

• 前收盤價: 19.86
• 開倉: 19.64
• 1 年變化: N/A
• 日區間: 19.2 - 19.74

Celon Pharma S.A. (WSE: CLN) is an innovative Polish biopharmaceutical company focused on research, development, and production of proprietary therapies in oncology, psychiatry, and inflammatory diseases. With in-house R&D capabilities and a growing clinical pipeline, Celon aims to commercialize novel molecules for global markets. Its dual strategy of proprietary drug development and generic manufacturing ensures revenue diversification. The company offers investors exposure to high-potential biotech innovation anchored in local production and scientific expertise.